Jul 30, 2026 04:07PM
Jul 30, 2026 04:05PM
Jul 23, 2026 04:06PM
Jul 23, 2026 04:05PM
Jul 1, 2026 09:07AM
Jul 1, 2026 09:06AM
Jul 1, 2026 08:37AM Abivax prices upsized $800M ADS offering at $125 per share
Jul 1, 2026 08:36AM
Jun 29, 2026 04:06PM
Jun 29, 2026 04:05PM
Jun 2, 2026 07:37AM
Jun 1, 2026 04:37PM
Jun 1, 2026 04:05PM
Jun 1, 2026 04:05PM Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
May 22, 2026 04:05PM
May 22, 2026 04:05PM
Apr 22, 2026 04:05PM
Mar 23, 2026 04:05PM
Feb 21, 2026 06:00AM
Jan 7, 2026 04:05PM
Dec 17, 2025 04:05PM Abivax secures 22 abstracts on inflammatory bowel disease drug at ECCO 2026
Dec 17, 2025 04:05PM
Dec 15, 2025 04:07PM
Nov 3, 2025 04:05PM
Nov 3, 2025 04:05PM
Oct 6, 2025 04:55AM
Oct 6, 2025 04:00AM
Oct 5, 2025 11:00AM Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Sep 29, 2025 04:05PM
Sep 29, 2025 04:05PM
Sep 23, 2025 04:05PM
Sep 23, 2025 04:05PM
Jul 23, 2025 04:17PM
Jul 23, 2025 04:15PM
Jul 23, 2025 07:54AM Abivax (ABVX) PT Raised to $74 at Leerink Partners
Jul 22, 2025 04:05PM
Jul 22, 2025 04:05PM
Apr 29, 2025 04:05PM
Apr 22, 2025 04:05PM
Apr 22, 2025 04:00PM
Apr 22, 2025 04:00PM
Jan 28, 2025 02:30AM Abivax Publishes 2025 Financial Calendar
Jan 9, 2025 11:35AM
Jan 2, 2025 12:51PM
Dec 23, 2024 04:07PM
Dec 23, 2024 04:05PM
Nov 19, 2024 04:31PM
Nov 19, 2024 04:30PM
Nov 14, 2024 04:01PM Abivax presents third quarter 2024 key financial information
Nov 13, 2024 04:03PM

328,249 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All